HPV16 Positive
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC (NCT03669718) | ISA Pharmaceuticals | 2018-11-30 |
| Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) (NCT00988559) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-09-01 |
Track HPV16 Positive automatically
Every clearance here is in the API, with alerts when new ones post.